For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseasesâincluding those in rheumatology, a therapeutic area inextricably linked to dermatologyâwe have rebranded the CRO side of our business to Indero. Our CRU will retain the name Innovaderm and will continue to conduct dermatology studies.
Dermatology is a diverse field of research with over 3,000 skin pathologies, greatly impacting patientsâ quality of life. Many skin conditions require new treatment optionsâand Indero has been dedicated to this need for over 25 years. With deep medical expertise and extensive operational experience, we can help you design a study that meets scientific objectives with the well-being of patients in mind.
As your dermatology CRO, Indero has experience with trials for atopic dermatitis, psoriasis, alopecia areata, and a variety of other dermatological indications. Our team has a deep understanding of the intricacies of skin-related conditions, applying depth and precision to each study we support, including:
Indero conducts safety and efficacy studies in dermatology, both involving systemic and topically administered investigational products.
Indero is a global clinical leader in dermatology with over a quarter-centuryâs experience serving a broad range of indications, patient populations, administration routes, and drug classes. From protocol design to data delivery, we offer a full-service approach that equips biotech and pharmaceutical sponsors with the scientific rigor and targeted expertise to help bring novel therapies to people with skin diseases. Our operations span across the world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Our dermatology connections include over 3,100+ investigators, making us a trusted partner for efficient, effective dermatology trials at a global scale.
âIndero’s flexibility and effective change management have been exceptional. They successfully integrated new study components, ensuring timelines were met and the project progressed seamlessly.”
Vice President, Clinical Operations
Innovaderm is a dermatology-focused Clinical Research Unit (CRU) well suited for single or multicenter dermatology studies. With a database of +90,000 patients, Innovaderm CRU has a dedicated team of study coordinators, lab technicians, research nurses, data entry specialists, regulatory specialists and recruitment professionals.
Indero has cultivated relationships with 3,100+ dermatology investigators around the world, actively contributing to the advancement of novel therapies for people with skin conditions. Developed over years of working together, we have strong relationships with these sites, allowing us to select the right sites for your trial. Our sites are ready to meet your enrollment requirements, ensuring your timelines and quality metrics are met.
A late phase clinical trial for 148 subjects across 41 sites in North America and Europe required smart site and patient recruitment strategies to fulfill enrollment requirements.
Head of Clinical Operations
âWorking with Indero for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.â
Meet our esteemed dermatologists, each bringing decades of invaluable experience to your trials. Their expertise is complemented by our dedicated operational CRO team, ready to support you at every stage.
Executive Chairman and Founder
Chief Medical and Scientific Officer
Dermatologist, Medical Monitor
Dermatologist, Medical Monitor Associate
When selecting a dermatology CRO, consider these key factors:
A specialized CRO enhances your trial by providing medical, scientific and clinical dermatology expertise in addition to tailored subject engagement strategies, and streamlined operations. Their deep understanding of regulatory requirements and established dermatology-specific networks can lead to more efficient trial execution and improved patient outcomes, ultimately advancing treatment options in this critical field.
Wherever
Youâre Going,
Weâre all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
Fields marked with * are required.
Looking for a partner for patient recruitment and advertising? Our dedicated patient recruitment and advertising team integrates with clinical trial sponsors and study teams to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced byâŻClinago, our technology-enabled recruitment service.
Leveraging an average of more than 15 years of industry experience, our seasoned clinical operations team offers both adaptive monitoring services (on-site and remote) and centralized monitoring services. All our team members undergo extensive dermatology training. We ensure compliance with dermatology study protocols, sound clinical practices, and applicable regulations. Our team is skilled in identifying data inconsistencies, performing trend analysis, and detecting patterns or outliers. Additionally, we offer tailored training programs for sites in dermatology to ensure they are well-equipped with the latest knowledge and best practices.
Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et dâopĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue dâĂ©tendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.
